Notable Journal Articles

Stephen M. Black serves as a Regents’ Professor with Georgia Regents University.  He aims to share his medical knowledge through peer-reviewed medical journals about heart disease and pulmonary hypertension. Two of his most popular articles  pertain to  increases in pulmonary vascular resistance and acute lung injury in patients with respiratory failure.

Inhaled Nitric Oxide-Induced Rebound Pulmonary Hypertension: Role for Endothelin-1

Stephen M. Black and other highly respectable medical research analysts conducted a research study that linked increases in pulmonary vascular resistance with the acute withdrawal of inhaled Nitric Oxide (NO). In conjunction with pulmonary hypertension, Stephen M. Black and his peers studied Endothelin (ET-1), which is an active peptide produced by the vascular endothelium. The factors derived from Endothelin are pulmonary heart disease and pulmonary hypertension in newborns.

The objective of this study was to determine the effects of inhaled NO on ET-1 production. They did this by comparing six one-month-old lambs who inhaled NO to six lamb models that did not inhale NO. From their research, Stephen M. Black and his team of medical researchers were able to investigate the effects of inhaled NO on ET-1 production through analysis of ET-1 concentrations in the newborn lambs during 24 hours of inhaled NO.

Learn more about this study here:

New Insights into Acute Lung Injury

In a recent study, Stephen M. Black collected data indicating the causes and effects of acute lung Injury (ALI) and acute respiratory distress syndrome (ARDS). These conditions are both due to progressive respiratory failure relating to acute onset of dyspnea, decreased arterial oxygen pressure, or hypoxemia and bilateral infiltrates on chest radiograms.  A statistics report made by the National Institute of Health states that every year 150,000 people in the United States are diagnosed with severe forms of ALI and ARDS.  In ALI/ARDS patients it is common for the separation between the alveolus and pulmonary circulation to be compromised by endothelial and /or epithelial injury. Undoubtedly, this study shows why lungs are  the organs most susceptible to damage and health issues caused by ALI/ARDS.

Read the full write-up on this study here:


Georgia Regents University

The Georgia Board of Regents voted in early 2012 to consolidate two of its universities, Georgia Health Sciences University and Augusta State University, to form a new university. The school approved its new mission statement in May and adopted the name “Georgia Regents University” (GRU) in August.

Georgia Regents University is now home to nearly 10,000 students and over 1,000 full-time faculty members. The university’s 150 buildings occupy more than 650 acres of land which is also home to an integrated health system and facilities for its growing intercollegiate athletic program.

Stephen M. Black Georgia Regents University

Stephen M. Black began teaching at Georgia Regents University in 2006

Georgia Regents University also boasts one of the most respected medical systems in the country, including the 478-bed Georgia Regents Medical Center. Other facilities on the medical campus are the Cancer Center, Medical College of Georgia, and the Children’s Hospital of Georgia. These facilities are run by roughly 1,100 enrolled medical students and a staff of over 1,000 professionally trained faculty members who instruct students while also conducting groundbreaking medical research. Stephen M. Black is one of the institution’s most decorated faculty members.

Stephen M. Black joined Georgia Regents University in April of 2006 as a Professor. He continued to gain additional responsibilities within the university, starting in July 2007 when he was appointed to Chief of the Program in Pulmonary Vascular Disease. One year later, Stephen M. Black also became the Basic Science Director for the Cardiovascular Discovery Institute. He still occupies both of these positions today.

In 2010 Stephen M. Black was promoted to Regents Professor, which is the highest honor bestowed by the University upon its professors. In this role Stephen M. Black not only instructs future medical professionals but also conducts influential medical research that he hopes will ease treatment for acute lung injury. He is currently the Principle Investigator/Project Leader for four active grants, and some of his medical students have even earned grants of their own

Learn more about Stephen M. Black and his research by visiting his Bigsight page or by connecting with him on Zerply:


Stephen M. Black is a medical researcher and professor at Georgia Regents University, and he has held this position since 2007. He has previously held teaching positions at University of Montana, Northwestern University, and University of California, San Francisco (UCSF). Before Stephen M. Black became involved in the medical education realm, he got his start as a student at the University of Edinburgh.

The University of Edinburgh was founded back in 1583 in Scotland’s capital. The public research university is now one of the most popular universities in the United Kingdom, receiving roughly 47,000 applicants per year. This means that the most recent admissions cycle saw 12 people apply for each place in the upcoming undergraduate class.

The University sees such a high volume of applicants because it is a highly-regarded educational institution that has taught some of history’s most respected thinkers. The 2012 QS Ranking named the University of Edinburgh the 21st best university in the world, making it the 6th best academic institution in Europe. The school’s alumni include inventor Alexander Graham Bell, author Sir Arthur Conan Doyle, former British Prime Minister Gordon Brown, and 15 Nobel Prize winners. (Learn more about the University here).

Stephen M. Black enrolled at the University of Edinburgh in 1982 to pursue his Bachelor of Science in Molecular Biology. The College of Medicine and Veterinary Medicine conferred this degree on him with honors in 1986. Stephen M. Black then continued his education at the University of Edinburgh by enrolling in the College of Medicine and Veterinary Medicine’s doctoral program. In 1990 he completed his Ph.D. in Molecular Pharmacology.

The College of Medicine and Veterinary Medicine has long been considered one of the best medical universities in the world. The medical school was ranked by the 2013 Good Times University Guide as the #1 medical school in Scotland and the #3 medical school in the United Kingdom.

Stephen M. Black’s ability to graduate from such a top-flight university explains why he has been so successful in his medical research career.

Learn more about Stephen M. Black’s medical research here: or by connecting with him on Viadeo.

Accomplished Medical Researcher

Stephen M. Black is currently a Regents Professor at Georgia Regents University, and spends a considerable amount of his time conducting medical research. He is involved in six medical research projects, which he discusses in detail on his personal blog, and has many more pending projects. Following completion of a project, Stephen M. Black shares what he has learned with the medical community by publishing his findings in journal articles. These articles are then reviewed by a group of his peers before being included in some of the medical community’s most prestigious publications. Stephen M. Black’s research has been featured in the Journal of Biological Chemistry, Journal of Molecular Science, and Journal of Cellular Biochemistry. Over 150 articles featuring his research have been published since 1989, when his first article appeared in Carcinogensis. One of Stephen M. Black’s most recent articles, which appeared in a 2011 issue of the American Heart Association’s Circulation, has received considerable attention:


Early Determinants of Pulmonary Vascular Remodeling in Animal Models of Complex Congenital Heart Disease

This article reviewed the state of medical knowledge concerning early changes in the pulmonary vasculature resulting from persistent systemic-to-pulmonary arterial shunting in newborn lambs, and how that knowledge changed following Stephen M. Black’s research. His study aimed to achieve a clearer understanding of the role of early vascular dysfunction in the development of pulmonary hypertension associated with single ventricle physiology.

Read the full article here:


While Stephen M. Black has been published in a number of established medical journals, he has also been asked to share his work in new journals. These publishers recognize that publishing an article by Stephen M. Black will enhance their own reputation, lending credibility for the new publication throughout the medical community. In 1994 he wrote an article for the very first issue of the journal Neurobiology of Disease:


NOS induction by NGF in basal forebrain cholinergic neurones: evidence for regulation of brain NOS by a neurotrophin

This article explained how nerve growth factor (NGF) serves as a trophic factor cholinergic neurons. Stephen M. Black’s research results indicated that brain nitric oxide synthase (NOS) can be regulated by a neurotrophic factor, suggesting that NGF influences brain function by regulating production of acetylcholine and nitric oxide.

Read the full article here:


Learn more about Stephen M. Black’s medical research by visiting his blog:

Administrative Appointments

Stephen M. Black is currently a Regents Professor with Georgia Regents University, but he also holds two administrative positions with the school. He was named the Chief of the Program in Pulmonary Vascular Disease in July of 2007. One year later, Stephen M. Black was appointed to the position of Basic Science Director with the university’s Cardiovascular Discovery Institute. These were not the first administrative appointments in Stephen M. Black’s career, as he has actually been appointed to administrative leadership positions in universities and medical facilities across the country. These facilities include:


University of California, San Francisco (UCSF)

UCSF is a public university that aims to save lives and improve health, and its USCF Medical Center was recently ranked among the Top 10 hospitals in the United States by the US News & World Report. Click here for more information about this medical center.

Stephen M. Black was named Laboratory Director of the UCSF Child Health Research Center in July of 1997, and he held that position until 1999 when he transitioned to Northwestern University.

Northwestern University

This private research university’s Feinberg School of Medicine has a medical campus located in Chicago’s Streeterville neighborhood. Among the medical school’s roughly 3,000 students are 719 MDs, 1,250 residents and fellows, 363 post-doctoral fellows, 353 PhD students, 296 Master’s students, and 400 Graduate Professional Program Students.

Stephen M. Black assumed the role of Research Director for the Division of Neonatology in 1999 and held this position until June 2003. The next month he was appointed to a leadership role with St. Patrick Hospital.

St. Patrick Hospital

This not-for-profit medical facility is located in Missoula, Montana and employs roughly 1,600 people. The facility was founded in 1873 and today holds 237 beds.

Stephen M. Black joined St. Patrick Hospital in 2003 as the Director of Vascular Biology, and stayed in this position until 2006. One year after joining St. Patrick Hospital, Stephen M. Black was appointed to a position with the University of Montana.

University of Montana

The University of Montana is also located in Missoula, and is considered the flagship of the Montana university system. The College of Health Professions and Biomedical Sciences conducts extensive medical training and clinical research.

Stephen M. Black became a COBRA Group Leader with the University of Montana in July, 2004. He held both positions in Missoula until 2006, when he left for Georgia Regents University.


Learn more about Stephen M. Black and his appointments by visiting his VisualCV.